MYC and lymphoma: In conclusion, an analysis of 93 cases, including our four cases, suggests that MYC rearrangement contributes to immature immunophenotypic profiles in both lymphoma and leukemia, emphasizing the importance of a refined classification that integrates morphology, immunophenotype, and genetics.